| Literature DB >> 36208905 |
Yi-Min Wan1, Daniel J van Wamelen2, Yue Hui Lau3, Silvia Rota3, Eng-King Tan4.
Abstract
The Coronavirus Disease 2019 (Covid-19) pandemic and the consequent restrictions imposed worldwide have posed an unprecedented challenge to research and training in Parkinson's disease (PD). The pandemic has caused loss of productivity, reduced access to funding, an oft-acute switch to digital platforms, and changes in daily work protocols, or even redeployment. Frequently, clinical and research appointments were suspended or changed as a solution to limit the risk of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) spread and infection, but since the care and research in the field of movement disorders had traditionally been performed at in-person settings, the repercussions of the pandemic have even been more keenly felt in these areas. In this chapter, we review the implications of this impact on neurological research and training, with an emphasis on PD, as well as highlight lessons that can be learnt from how the Covid-19 pandemic has been managed in terms of restrictions in these crucial aspects of the neurosciences. One of the solutions brought to the fore has been to replace the traditional way of performing research and training with remote, and therefore socially distanced, alternatives. However, this has introduced fresh challenges in international collaboration, contingency planning, study prioritization, safety precautions, artificial intelligence, and various forms of digital technology. Nonetheless, in the long-term, these strategies will allow us to mitigate the adverse impact on PD research and training in future crises.Entities:
Keywords: Covid-19; Impact; Movement disorders; Parkinson's disease; Research; Training
Mesh:
Year: 2022 PMID: 36208905 PMCID: PMC9066297 DOI: 10.1016/bs.irn.2022.04.003
Source DB: PubMed Journal: Int Rev Neurobiol ISSN: 0074-7742 Impact factor: 4.280
Fig. 1The impact of Covid-19 pandemic and related restrictions on Parkinson's disease research and training.
Fig. 2The strategies effected to mitigate the impact of Covid-19 pandemic on Parkinson's Disease research and training.
Fig. 3The decline in the number of studies in people with Parkinson's disease over the year 2021 compared to the preceding 5 years; note the even greater decline in the number of clinical trials and randomized clinical trials (RCT).